Rituximab and poor-risk follicular lymphoma Journal Article


Author: Moskowitz, C. H.
Article Title: Rituximab and poor-risk follicular lymphoma
Abstract: Rituximab is commonly administered by itselft or with chemotherapy in patients with follicular lymphoma. Now we have randomized data to support the use of rituximab and CVP in untreated follicular lymphoma with unfavorable prognostic features.
Journal Title: Blood
Volume: 105
Issue: 4
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2005-02-15
Start Page: 1380
End Page: 1380
Language: English
DOI: 10.1182/blood-2004-11-4538
ACCESSION: WOS:000226970800010
PROVIDER: wos
Notes: --- - Editorial Material - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Craig Moskowitz
    407 Moskowitz